20 14124 October, 65438+ was successfully listed as the "new third board" (the national share system for small and medium-sized enterprises). The stock is called Weimen Pharmaceutical for short, and the stock generation is 430369.
It owns three wholly-owned subsidiaries: Guizhou Xingqian Technology Development Co., Ltd., Guizhou Tongwei Biotechnology Co., Ltd. and Guizhou Weimentang Pharmaceutical Chain Co., Ltd., which are mainly engaged in the research and development, production and sales of big health products and the cultivation and sales of raw materials.
The company has production lines such as capsules, granules, tablets, powder injections and freeze-dried powder injections. The sales network covers more than 300 large and medium-sized cities in more than 30 provinces, municipalities and autonomous regions except the whole country. In 2009, the Vietnamese market was successfully opened, and the Hong Kong market achieved sales of 20 14 and 12.
Its three wholly-owned subsidiaries are mainly engaged in the research and development, production and sales of big health products and the cultivation and sales of raw materials.
Among them, Guizhou Xingqian Technology Development Co., Ltd. owns 1 10,000 mu of Polygonum capitatum GAP planting base and 500 mu of high-quality Dendrobium candidum breeding base, and has launched Dendrobium candidum health wine, fresh Dendrobium candidum strips, freeze-dried Dendrobium candidum flowers and other products. Guizhou Tongwei Biotechnology Co., Ltd. mainly develops and produces health care products, decoction pieces and direct oral decoction pieces, and has successively launched 8 series of gastrodia elata products, such as fresh gastrodia elata freeze-dried powder and gastrodia elata honey tablets. The establishment of Guizhou Weimentang Pharmaceutical Chain Co., Ltd. is an important measure for Weimen Group to adapt to the new normal, seize new opportunities and conform to the development trend of "internet plus".
In addition to selling Weimen Group's products, the company will also sell most of the precious fine medicinal materials online and offline with high quality and low price, so as to realize online and offline integrated linkage sales of all product lines of Weimen Group, such as OTC, health products, decoction pieces and granules.
Looking forward to the future, Weimen Pharmaceutical will adhere to the keynote of "strengthening Miao medicine, expanding Miao medicine and developing big health industry" and the strategy of "one body, two wings and one support", and continue to implement the ideas of "four modernizations management", "adjustment in development" and "fine cost management".
While carrying out the secondary development of large-scale products, it integrates planting, production, health care and old-age services around the concept of "Great Health in internet plus" and develops rapidly along the direction of collectivization, diversification and internationalization.
Product classification: pharmaceutical brand concept: brand origin: Guiyang City, Guizhou Province, responsible person: Liang Tel: 085 1-8630-0666 Brand year: 1996.